Skip to main content
. 2022 Mar 10;12:4223. doi: 10.1038/s41598-022-07919-5

Table 2.

Multivariate linear regression analysis for associated factors of renal function change at postoperative 12 months after partial nephrectomy.

Univariated analysis Multivariable analysis
B (95% CI) p value B (95% CI) p value
Age, year 0.158 (− 0.150 to 0.467) 0.331
Body mass index (kg/m2) − 1.132 (− 2.391 to 0.127) 0.077
Diabetes 0.754 (− 8.890 to 10.398) 0.877
Hypertension 6.145 (− 1.343 to 13.633) 0.097
Preoperative eGFR (ml/min/1.73m2) − 0.22 (− 0.400 to − 0.039) 0.018 − 0.367 (− 0.598 to − 0.137) 0.020
Ischemic time (min) − 0.251 (− 0.687 to 0.184) 0.254
Ischemic type 7.822 (0.435 to 15.208) 0.038 6.788 (0.982 to 13.789) 0.042
Operative time (min) − 0.084 (− 0.227 to 0.058) 0.244
EBL (mL) − 0.004 (− 0.023 to 0.016) 0.717
Tumor largest diameter (cm) 1.879 (− 2.742 to 6.500) 0.421
Tumor volume (cm3) 0.179 (− 0.315 to 0.673 0.474
RENAL score 2.796 (− 0.107 to 5.700) 0.059
Parenchyma thickness
Preoperative (mm) − 0.756 (− 2.401 to 0.889) 0.357
Postoperative (mm) − 0.993 (− 2.424 to 0.439) 0.116
Percent change (%) − 0.822 (− 2.089 to 0.445) 0.008 0.797 (0.086 to 1.508) 0.029
Parenchymal enhancement ratio
Preoperative − 0.117 (− 0.739 to 0.505) 0.106
Postoperative − 0.621 (− 1.182 to − 0.060) 0.242
Percent change (%) 0.059 (− 0.434 to 0.552) 0.595

B unstandardized coefficient, CI confidence interval, eGFR estimated glomerular filtration rate, EBL estimation of blood loss, RENAL RENAL nephrometry score, Parenchymal enhancement ratio the ratio of the parenchyma enhancement (HU) to the aorta enhancement (HU).